Automated cell counters are instruments used to count and analyze cells in biological samples with high precision and accuracy. The automated process helps save time and offers reproducibility as compared to manual cell counting. Advancements in cell counting techniques such as integration of artificial intelligence (AI) and machine learning have enabled automated cell counters to analyze complex samples with multiple cell types.
The global Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The integration of AI and machine learning in automated cell counters has been a key trend driving the market growth over the recent years. AI-powered cell counters can analyze images of cells taken under the microscope and identify different cell types based on various attributes such as size, shape, texture, color, etc. This enables analysis of complex biosamples containing multiple cell types simultaneously. AI techniques help program the cell counters to continuously learn from vast microscopy images during their usage and improve the accuracy of cell identification and counting over time without needing reprogramming. Leading automated cell counter manufacturers are focusing on incorporating advanced AI capabilities in their products to deliver enhanced performance for complex cell analysis. This ongoing technology advancement is expected to boost the demand for automated cell counters during the forecast period.
Segment Analysis
The global automated cell counters market is segmented by product, application and end-use. The product segment is further divided into hematology analyzer, flow cytometer and others. Hematology analyzer dominates the product segment as it offers fully automated solutions for analyzing blood sample rapidly with accurate results. The applications covered in this market are research applications, clinical diagnostics and others. Clinical diagnostics dominates the application segment as automated cell counters are widely used across different pathology labs, hospitals and research centers for accurate diagnosis. The end-use segment covered are research institutes, hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies. Hospitals & clinical testing laboratories dominates as cell counters help improve workflow efficiency and accuracy in diagnosis.
Key Takeaways
The global automated cell counters market is expected to witness high growth over the forecast period owing to rapid technological advancements in cell counting devices. The global Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030.
Regional analysis
North America dominates the global automated cell counters market currently due to availability of advanced healthcare infrastructure and presence of key players. Asia Pacific is expected to grow at the fastest rate during the forecast period due to increasing healthcare expenditure, rising awareness about cell analysis and growing research activities in the region.
Key players
Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA. Thermo Fisher Scientific and Danaher Corporation dominates the market due to their diverse product portfolio and strong global presence.
No comments:
Post a Comment